mhurhangee/ep-ind-claims huggingface dataset:
A lifting device for an inspection system and/or a cleaning system, in particular for lifting a camera device or a flushing device, the lifting device having a base support and a lifting unit movable with respect to the base support, said lifting device having at least one setting means cooperating with the lifting unit for moving said lifting unit, characterised in that - the setting means has at least one shape memory element capable of reversibly changing its shape depending on at least one influence factor, - the change in the shape of the shape memory element causes the lifting unit to be moved with respect to the base support. - the setting means has at least one shape memory element capable of reversibly changing its shape depending on at least one influence factor, - the change in the shape of the shape memory element causes the lifting unit to be moved with respect to the base support.
Method for operating a steam cycle process for utilizing the waste heat of an internal combustion engine, the steam cycle process comprising a line circuit in which a working medium can be circulated, a feed pump, at least one heat exchanger, an expansion machine, a feed water tank in order to store the liquid working medium, and a condenser, the feed pump being arranged between the feed water tank and the heat exchanger, characterized in that, after the end of circulation of the working medium, the feed pump is subsequently operated, in order to empty the working medium at least out of the subsequently operated feed pump whereby components of the line circuit are made frost-proof as a result of the partial emptying of the liquid working medium.
A monoclonal antibody or an antigen-binding fragment thereof that specifically binds to Dual Immunoglobulin domain containing Cell Adhesion Molecule (DICAM) to an epitope located within a domain consisting of residues 57-71 of SEQ ID NO: 18, wherein the antibody or antigen-binding fragment thereof blocks or inhibits the binding of DICAM to αYβ3 integrin and blocks or inhibits the migration of TH17 lymphocytes across a vascular epithelium or endothelium.
Conveyor for moving four-wheeled vehicles, comprising a telescopic frame provided with tire-chock arms movable between a retracted position and a position in which they engage with the treads of said wheels, characterized in that it further comprises a propulsion unit made up of a front frame to which two lateral subunits (110, 120) are secured, each comprising a motorized and directional wheel (111, 121) which can be oriented independently of one another and a means for coupling said telescopic frame with said front frame.
A method for generating cryptographic key pairs in public key cryptography, the method comprising: randomly generating a table having a plurality of table entries, each table entry comprising a plurality of group elements, each group element in a table entry of the plurality of table entries having a same discrete logarithm to a corresponding base, the corresponding bases of the discrete logarithms being the same for each table entry; randomly selecting table entries from the plurality of the table entries of the randomly generated table; computing intermediate table entries from combinations of the selected table entries, each intermediate group element in an intermediate table entry having a same discrete logarithm to a corresponding base, and the corresponding bases of the discrete logarithms of the intermediate group elements being the same as for the table entries; replacing the selected table entries with randomly selected intermediate table entries to produce an updated table; and randomly selecting a table entry of the updated table and providing it as a cryptographic key pair. randomly generating a table having a plurality of table entries, each table entry comprising a plurality of group elements, each group element in a table entry of the plurality of table entries having a same discrete logarithm to a corresponding base, the corresponding bases of the discrete logarithms being the same for each table entry; randomly selecting table entries from the plurality of the table entries of the randomly generated table; computing intermediate table entries from combinations of the selected table entries, each intermediate group element in an intermediate table entry having a same discrete logarithm to a corresponding base, and the corresponding bases of the discrete logarithms of the intermediate group elements being the same as for the table entries; replacing the selected table entries with randomly selected intermediate table entries to produce an updated table; and randomly selecting a table entry of the updated table and providing it as a cryptographic key pair.
A method for the manufacture of a sample in amorphous form for dynamic nuclear polarization which comprises submitting a solid substrate in a crystalline form to a milling process in the presence of a polarizing agent at a temperature lower than the glass-transition temperature (Tg) of said substrate.
A method for evaluating in a whole blood sample from a subject the number of T-cells bearing CD4 comprising a cytoplasmic (cytosolic) and an extracellular (ecto) domain, the method comprising: (i) contacting the sample with an agent capable of lysing or permeabilizing CD4 bearing T-cells; (ii) contacting the sample with a CD4-binding antibody or antigen-binding fragment thereof that binds to the cytoplasmic domain of the CD4; (iii) directly or indirectly evaluating the level or presence of bound CD4 in the sample; and (iv) determining the number of CD4 bearing cells in the sample by comparing the level or presence of bound CD4 or a bound detection marker with a predetermined control, wherein the level or presence of bound CD4 comprising at least a cytoplasmic domain is indicative of the number of CD4 bearing T-cells in the subject, wherein the method does not detect soluble CD4 lacking the cytoplasmic domain and distinguishes between cell-associated CD4 comprising a cytoplasmic domain and soluble CD4 lacking a cytoplasmic domain. (i) contacting the sample with an agent capable of lysing or permeabilizing CD4 bearing T-cells; (ii) contacting the sample with a CD4-binding antibody or antigen-binding fragment thereof that binds to the cytoplasmic domain of the CD4; (iii) directly or indirectly evaluating the level or presence of bound CD4 in the sample; and (iv) determining the number of CD4 bearing cells in the sample by comparing the level or presence of bound CD4 or a bound detection marker with a predetermined control,
A control device for use in woven article, comprising: a conductive fabric, which comprises a plurality of conductive warps, a plurality of conductive wefts, and a plurality of insulation warps, the insulation warps being arranged between the conductive warps and the conductive wefts, the conductive warps being selectively and releasably set in electrical engagement with the conductive wefts to form plurality of conduction sites; and a woven flat cable unit, which comprises at least one first woven flat cable, the first woven flat cable comprising a plurality of conductor lines, the first woven flat cable being set to overlap the conductive fabric, two of the conductor lines being respectively and electrically connected to the conductive warp and the conductive weft of one of the conduction sites of the conductive fabric; and a processor unit, which is electrically connected to the conductor lines of the first woven flat cable. a conductive fabric, which comprises a plurality of conductive warps, a plurality of conductive wefts, and a plurality of insulation warps, the insulation warps being arranged between the conductive warps and the conductive wefts, the conductive warps being selectively and releasably set in electrical engagement with the conductive wefts to form plurality of conduction sites; and a woven flat cable unit, which comprises at least one first woven flat cable, the first woven flat cable comprising a plurality of conductor lines, the first woven flat cable being set to overlap the conductive fabric, two of the conductor lines being respectively and electrically connected to the conductive warp and the conductive weft of one of the conduction sites of the conductive fabric; and a processor unit, which is electrically connected to the conductor lines of the first woven flat cable.
A method for wireless communication, comprising: performing, by a user equipment, UE, a transmission in a serving cell using an active bandwidth part of the serving cell representing a first contiguous subset of physical resource blocks; and switching, by the UE, to a pre-configured bandwidth part of the serving cell representing a second contiguous subset of physical resource blocks to perform subsequent transmissions upon determining that there is no configured random-access resource available for initiating a random access procedure. performing, by a user equipment, UE, a transmission in a serving cell using an active bandwidth part of the serving cell representing a first contiguous subset of physical resource blocks; and switching, by the UE, to a pre-configured bandwidth part of the serving cell representing a second contiguous subset of physical resource blocks to perform subsequent transmissions upon determining that there is no configured random-access resource available for initiating a random access procedure.
A method performed by a zone controller (110a-e, 410, 410a-c) for a zone of a building for improving energy efficiency in a heating, ventilation, and air conditioning (HVAC) system, comprising: operating in a ventilation mode; monitoring a temperature of the zone; monitoring outside air conditions for the building; determining (506, 508) whether to switch from the ventilation mode to an economizing mode based on a first set point for the temperature of the zone and based on the outside air conditions, wherein the first set point is determined based on a second set point for the temperature different from the first set point; and determining whether to activate the HVAC system based on the second set point. operating in a ventilation mode; monitoring a temperature of the zone; monitoring outside air conditions for the building; determining (506, 508) whether to switch from the ventilation mode to an economizing mode based on a first set point for the temperature of the zone and based on the outside air conditions, wherein the first set point is determined based on a second set point for the temperature different from the first set point; and determining whether to activate the HVAC system based on the second set point.
A secondary battery, comprising a first electrode assembly, a second electrode assembly, a case and a top cap assembly; the first electrode assembly and the second electrode assembly are housed in the case; the top cap assembly comprises a top cap plate and a first electrode terminal, the top cap plate is connected to the case, and the first electrode terminal is arranged on the top cap plate; the first electrode assembly comprises a first body and first tabs extending from the first body, and the first tabs are multiple and stacked; the second electrode assembly comprises a second body and second tabs extending from the second body, and the second tabs are multiple and stacked; the second tabs are bent toward a direction approaching the first tabs and connected to the first tabs, and an end of each of the second tabs that is away from the second body is a second end portion; each of the first tabs comprises a first connecting portion extending beyond the second end portions of the second tabs, and the first connecting portion is connected to the first electrode terminal. the first electrode assembly and the second electrode assembly are housed in the case; the top cap assembly comprises a top cap plate and a first electrode terminal, the top cap plate is connected to the case, and the first electrode terminal is arranged on the top cap plate; the first electrode assembly comprises a first body and first tabs extending from the first body, and the first tabs are multiple and stacked; the second electrode assembly comprises a second body and second tabs extending from the second body, and the second tabs are multiple and stacked; the second tabs are bent toward a direction approaching the first tabs and connected to the first tabs, and an end of each of the second tabs that is away from the second body is a second end portion; each of the first tabs comprises a first connecting portion extending beyond the second end portions of the second tabs, and the first connecting portion is connected to the first electrode terminal.
Apparatus comprising: a housing having an aperture configured to receive a body part of a user; a shaft within the housing; a capacitive sensor supported on the housing; a plurality of testing members (208, 209, 210) rotatably mounted on the shaft, wherein each of the plurality of testing members is independently rotatable about the shaft, and wherein each of the plurality of testing members supports a lancet which protrudes from each respective member, wherein the apparatus is configured to rotate a first one of the plurality of testing members which is aligned with the aperture so as to cause the lancet supported by the first one of the plurality of testing members to lance the body part of the user which is received in the aperture; and a controller configured to use the capacitive sensor to determine whether a body part of a user is present within the aperture and to permit lancing of the body part only when it is determined that the body part of the user is present in the aperture; wherein the apparatus is constructed such that different ones of the plurality of testing members are able to be presented at the aperture in turn. a housing having an aperture configured to receive a body part of a user; a shaft within the housing; a capacitive sensor supported on the housing; a plurality of testing members (208, 209, 210) rotatably mounted on the shaft, wherein each of the plurality of testing members is independently rotatable about the shaft, and wherein each of the plurality of testing members supports a lancet which protrudes from each respective member, wherein the apparatus is configured to rotate a first one of the plurality of testing members which is aligned with the aperture so as to cause the lancet supported by the first one of the plurality of testing members to lance the body part of the user which is received in the aperture; and a controller configured to use the capacitive sensor to determine whether a body part of a user is present within the aperture and to permit lancing of the body part only when it is determined that the body part of the user is present in the aperture; wherein the apparatus is constructed such that different ones of the plurality of testing members are able to be presented at the aperture in turn.
An oligonucleotide or modified oligonucleotide containing at least one unmethylated CpG dinucleotide motif for use in a method for treating Alzheimer's Disease pathology, which method comprises: administering once or twice weekly, to a subject in need thereof at a dosage in the range of 1 μg to 10 mg per kilogram of body weight, wherein said administering is effective to stimulate production of autoantibodies having binding specificity for one or more pathological neo-epitopes of amyloid beta or a beta-amyloid-associated protein without co-administration of exogenous immunogens, thereby treating Alzheimer's Disease pathology.
Compound having formula and pharmaceutically accepted salts thereof, wherein X is oxygen, nitrogen or sulfur, Y represents an aromatic ring or heterocyclic ring comprising at least a nitrogen, optionally substituted by one or more substituents independently selected from C 1-6 alkyl, C 1 - 4 alkoxy, trifluoromethyl or halogen, Z represents C 1-10 saturated or unsaturated alkyl optionally substituted by an alkyl or alkylhydroxyl; or Z represents C 1-6 alkyl -NH-C -C 1-6 alkyl-, C 1 - 6 alkyl-NH- or C 1-6 alkyl -NH-C - C 1-6 alkyl-O-; or Z represents C 1-10 alkyl-O- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl., or Z represents C 1-6 alkyl-O-C 1-6 alkyl- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl or Z represents C 1-6 alkyl-O-C 1-6 alkyl-O- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl. X is oxygen, nitrogen or sulfur, Y represents an aromatic ring or heterocyclic ring comprising at least a nitrogen, optionally substituted by one or more substituents independently selected from C 1-6 alkyl, C 1 - 4 alkoxy, trifluoromethyl or halogen, Z represents C 1-10 saturated or unsaturated alkyl optionally substituted by an alkyl or alkylhydroxyl; or Z represents C 1-6 alkyl -NH-C -C 1-6 alkyl-, C 1 - 6 alkyl-NH- or C 1-6 alkyl -NH-C - C 1-6 alkyl-O-; or Z represents C 1-10 alkyl-O- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl., or Z represents C 1-6 alkyl-O-C 1-6 alkyl- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl or Z represents C 1-6 alkyl-O-C 1-6 alkyl-O- wherein said alkyl is unsaturated or saturated and can optionally be substituted by an alkyl or alkylhydroxyl.
A method for using a mobile information gateway for home healthcare, the method comprising: capturing information with one or more of an imaging device, an audio recording device, and a patient monitoring device operatively coupled to a wearable human interface module, in order to perform monitoring of a patient; processing the captured information to determine an identity of a user of the wearable human interface module; authenticating the identity of user; retrieving information using the captured information and the authenticated identity; presenting the retrieved information using the wearable human interface module; capturing additional information about a medication, the additional information comprising image information describing an image of a packaging of the medication; processing the captured additional information about the medication to identify a type of medication; determining whether the type of medication is prescribed for the identity of the user; determining whether one or more conditions for taking the type of medication are satisfied; and sending a warning message for presentation by the wearable human interface module if either the type of medication is not prescribed for the identity of the user or one or more conditions for taking the type of medication are not satisfied. capturing information with one or more of an imaging device, an audio recording device, and a patient monitoring device operatively coupled to a wearable human interface module, in order to perform monitoring of a patient; processing the captured information to determine an identity of a user of the wearable human interface module; authenticating the identity of user; retrieving information using the captured information and the authenticated identity; presenting the retrieved information using the wearable human interface module; capturing additional information about a medication, the additional information comprising image information describing an image of a packaging of the medication; processing the captured additional information about the medication to identify a type of medication; determining whether the type of medication is prescribed for the identity of the user; determining whether one or more conditions for taking the type of medication are satisfied; and sending a warning message for presentation by the wearable human interface module if either the type of medication is not prescribed for the identity of the user or one or more conditions for taking the type of medication are not satisfied.
A method for assessing the EGFR status of a tissue sample comprising: processing said tissue sample with reagents to produce distinguishable signals corresponding to the presence or absence of a L858R EGFR mutation, an exon 19 deletion EGFR mutation and EGFR gene amplification; and simultaneously visualizing said distinguishable signals. processing said tissue sample with reagents to produce distinguishable signals corresponding to the presence or absence of a L858R EGFR mutation, an exon 19 deletion EGFR mutation and EGFR gene amplification; and simultaneously visualizing said distinguishable signals.
A rotor blade with a rotor blade connection for connecting the rotor blade to a rotor hub of a wind turbine, using an attachment body, wherein the attachment body is provided for arrangement in a seat of the rotor blade connection of the rotor blade and wherein the seat is configured at the end on the rotor hub face of the preferably flange-free rotor blade, wherein the attachment body becomes or is arranged in the seat between an inside attachment face and an outside attachment face of the rotor blade and the attachment body inserted into the seat becomes or is connected to the inside attachment face and the outside attachment face of the rotor blade, wherein the attachment body tapers in its longitudinal extension, wherein the attachment body has, transversely, in particular vertically, to the longitudinal extension, a connection for a lightning conductor of the rotor blade, characterised in that the attachment body has a depression, in particular a drilled hole, on its head end facing the inside face of the rotor blade, for receiving a connection piece projecting from the head end of the attachment body, wherein the connection piece becomes or is connected to the end of the lighting conductor.
A method for manufacturing a filter material and/or filler material for mouthpieces for use in smoking products or HNB products consisting of cellulose acetate filaments and/or cellulose acetate staple fibers, wherein a solution of cellulose acetate having an acetyl value of at least 53% in acetone is pressed through a spinneret having multiple openings, and wherein the cellulose acetate filaments are then cut into cellulose acetate staple fibers as needed and wherein a multitude of the cellulose acetate filaments and/or cellulose acetate staple fibers thus obtained are gathered into a filter tow which is crimped as applicable, wherein the spinneret through which the solution of cellulose acetate is pressed is designed such that hollow cellulose acetate filaments are spun, wherein - in relation to a cut orthogonal to the fibers of the filter material and/or filler material - the hollow portion in the filter material and/or filler material amounts to 25% to 90% and preferably 50% to 80%, and wherein the filament diameter of the cellulose acetate filaments is in a range of between 60 to 100 μm.